Pasithea Therapeutics Corp. Share Price
KTTAPasithea Therapeutics Corp. Stock Performance
Open $0.68 | Prev. Close $0.69 | Circuit Range N/A |
Day Range $0.68 - $0.69 | Year Range $0.29 - $3.79 | Volume 1,293 |
Average Traded $0.68 |
Pasithea Therapeutics Corp. Share Price Chart
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Pasithea Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Apr-26 | $0.68 | $0.71 | +0.00% |
30-Apr-26 | $0.68 | $0.71 | +2.77% |
29-Apr-26 | $0.68 | $0.69 | +2.08% |
28-Apr-26 | $0.68 | $0.67 | -2.46% |
27-Apr-26 | $0.68 | $0.69 | -0.58% |
24-Apr-26 | $0.70 | $0.69 | +0.73% |
23-Apr-26 | $0.71 | $0.69 | -3.09% |
FAQs on Pasithea Therapeutics Corp. Share Price
Can I buy Pasithea Therapeutics Corp. shares in India?
What is the share price of Pasithea Therapeutics Corp.?
What is the 5 year returns of Pasithea Therapeutics Corp.?
What are the high & low stock price of Pasithea Therapeutics Corp. today?
What is the 52-week high and low of Pasithea Therapeutics Corp. stock?